- Koronární stenty uvolňující farmaka (DES - Drug Eluting Stents) - revoluce v léčbě ischemické choroby srdeční2004 | 1. lékařská fakulta
- The SPIRIT V study: a clinical evaluation of the XIENCE V everolimus-eluting coronary stent system in the treatment of patients with de novo coronary artery lesions2011 | Lékařská fakulta v Hradci Králové
- Long-term follow-up of percutaneous coronary intervention of unprotected left main lesions with drug eluting stents: predictors of clinical outcome2009 | 3. lékařská fakulta
- Titanový stent - nová éra v intervenční kardiologii?2011 | Publikace bez příslušnosti k fakultě
- Pozdní trombóza stentů - nový, málo častý, ale závažný problém2006 | 1. lékařská fakulta
- Long-term outcomes of patients receiving zotarolimus-eluting stents in ST elevation myocardial infarction, non-ST elevation acute coronary syndrome, and stable angina: Data from the Resolute program2013 | 3. lékařská fakulta
- Antiplatelet Therapy Duration Following Bare Metal or Drug-Eluting Coronary Stents The Dual Antiplatelet Therapy Randomized Clinical Trial2015 | Publikace bez příslušnosti k fakultě
- Long-Term Health Outcome and Mortality Evaluation After Invasive Coronary Treatment Using Drug Eluting Stents with or without the IVUS Guidance. Randomized Control Trial. HOME DES IVUS2010 | Publikace bez příslušnosti k fakultě
- Incidence and predictors of unplanned non-target lesion revascularisation up to three years after drug-eluting stent implantation: insights from a pooled analysis of the RESOLUTE Global Clinical Trial Program2016 | 3. lékařská fakulta
- Patterns of Long-term Thienopyridine Therapy and Outcomes in Patients With Acute Coronary Syndrome Treated With Coronary Stenting: Observations From the TIMI-38 Coronary Stent Registry2014 | 3. lékařská fakulta
- The influence of age on clinical outcomes in patients treated with the resolute zotarolimus-eluting stent2016 | 3. lékařská fakulta
- Stent Selection for Primary Angioplasty and Outcomes in the Era of Potent Antiplatelets. Data from the Multicenter Randomized Prague-18 Trial2021 | 1. lékařská fakulta, 3. lékařská fakulta, Ústřední knihovna
- Usefulness and Safety of Vorapaxar in Patients With Non-ST-Segment Elevation Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention (from the TRACER Trial)2014 | 3. lékařská fakulta
- Absorb Bioresorbable Scaffold Versus Xience Metallic Stent for Prevention of Restenosis Following Percutaneous Coronary Intervention in Patients at High Risk of Restenosis: Rationale and Design of the COMPARE ABSORB Trial2019 | 3. lékařská fakulta
- Impact of overlapping newer generation drug-eluting stents on clinical and angiographic outcomes: pooled analysis of five trials from the international Global RESOLUTE Program2013 | 3. lékařská fakulta
- Clinical Outcomes of the Resolute Zotarolimus-Eluting Stent in Patients With In-Stent Restenosis2013 | 3. lékařská fakulta
